Stay updated on IPF/ILD-PRO Clinical Trial of Novel Therapy
Sign up to get notified when there's something new on the IPF/ILD-PRO Clinical Trial of Novel Therapy page.

Latest updates to the IPF/ILD-PRO Clinical Trial of Novel Therapy page
- Check3 days agoChange DetectedThe page shows a revision bump from v3.6.3 to v3.6.4, indicating a minor backend or UI update to the ClinicalTrials.gov page.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedPhone number formatting changed from 216-445-0574 to 2164450574, and new date stamps were added to reflect administrative page updates. These changes relate to page metadata rather than the core study content.SummaryDifference0.2%

- Check25 days agoChange DetectedRevision tag updated from v3.6.2 to v3.6.3, indicating a small update to the study record's metadata.SummaryDifference0.0%

- Check32 days agoChange DetectedThe page's revision label changes from v3.6.0 to v3.6.2, indicating a minor update to the page's version in the metadata.SummaryDifference0.0%

- Check39 days agoChange DetectedNew publication citation added to Publications: Swaminathan AC, Mulder H, Neely ML, Schmid R, Belperio JA, Patel NM, Palmer SM, Todd JL. Expression of complement pathway genes is associated with progression of idiopathic pulmonary fibrosis. Respir Res. 2026 Mar 25;27(1):196, doi: 10.1186/s12931-026-03641-2. This entry links a registry-related study to the IPF-PRO publications list.SummaryDifference0.0%

- Check46 days agoChange DetectedNew navigation links were added to the study page to guide potential participants (including checking eligibility, contact information, and joining steps), with the page revision updated to v3.6.0; the older revision label v3.5.5 was removed.SummaryDifference0.2%

Stay in the know with updates to IPF/ILD-PRO Clinical Trial of Novel Therapy
Enter your email address, and we'll notify you when there's something new on the IPF/ILD-PRO Clinical Trial of Novel Therapy page.